Arianna Goracci
Overview
Explore the profile of Arianna Goracci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
469
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Maccora C, Ciuoli C, Goracci A, Benenati N, Formichi C, Pilli T, et al.
Endocr Pract
. 2019 Nov;
26(2):235-240.
PMID: 31682516
Liraglutide is a glucagon-like peptide 1 receptor agonist which acts through peripheral and central receptor pathways affecting food intake. Preliminary identification of responder patients represents a crucial point to reduce...
22.
Cuomo A, Aguglia A, Aguglia E, Bolognesi S, Goracci A, Maina G, et al.
Bipolar Disord
. 2019 Oct;
22(4):385-391.
PMID: 31630470
Background: Several studies have challenged the traditional unipolar-bipolar dichotomy in favor of a more dimensional approach. Objective: To evaluate the differences in mood spectrum between patients with bipolar disorder (BD)...
23.
Cuomo A, Beccarini Crescenzi B, Goracci A, Bolognesi S, Giordano N, Rossi R, et al.
Expert Opin Drug Saf
. 2019 May;
18(6):455-463.
PMID: 31072228
: Safety and tolerability of medications are key variables to inform treatment choice for patients with bipolar disorder (BD). This review focuses on the overall tolerability and safety profile of...
24.
Cuomo A, Maina G, Bolognesi S, Rosso G, Beccarini Crescenzi B, Zanobini F, et al.
Front Psychiatry
. 2019 Apr;
10:167.
PMID: 31001150
Vitamin D inadequacy or deficiency (VDID) has been reported in a high percentage of otherwise healthy individuals. Factors that may contribute to the high prevalence of VDID in people with...
25.
Cuomo A, Bolognesi S, Goracci A, Ciuoli C, Beccarini Crescenzi B, Maina G, et al.
Front Psychiatry
. 2019 Feb;
9:784.
PMID: 30728788
Liraglutide is a once-daily injectable medication approved for the treatment of obesity. Hereby we report the feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood...
26.
Amodeo G, Cuomo A, Bolognesi S, Goracci A, Trusso M, Piccinni A, et al.
Expert Opin Pharmacother
. 2019 Jan;
20(6):679-690.
PMID: 30696303
Introduction: Binge eating disorder (BED) is the most common eating disorder and was newly recognized in 2013 in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders...
27.
Ballerio M, Politi P, Crapanzano C, Emanuele E, Cuomo A, Goracci A, et al.
Neuro Endocrinol Lett
. 2018 Nov;
39(3):205-208.
PMID: 30431739
Objectives: Trazodone is a multifunctional triazolopyridine drug with antidepressant, anxiolytic, sedative, and hypnotic properties. The current retrospective study was designed to investigate the effectiveness of trazodone for reducing acute psychomotor...
28.
Cuomo A, Maina G, Rosso G, Beccarini Crescenzi B, Bolognesi S, Di Muro A, et al.
Front Pharmacol
. 2018 Oct;
9:1040.
PMID: 30374300
The gastrointestinal system hosts roughly 1,800 distinct phyla and about 40,000 bacterial classes, which are known as microbiota, and which are able to influence the brain. For instance, microbiota can...
29.
Cuomo A, Maina G, Neal S, De Montis G, Rosso G, Scheggi S, et al.
Expert Opin Drug Saf
. 2018 Jun;
17(7):719-725.
PMID: 29927667
Introduction: The World Health Organization recommends newborns to be breastfed but this may be challenging if the mother needs to be treated for depression, since strong evidence to inform treatment...
30.
Fagiolini A, Amodeo G, Goracci A, Blardi P
Riv Psichiatr
. 2016 Oct;
51(4):123-128.
PMID: 27727261
Aim: This paper examines the use of Trazodone Contramid® in major depressive disorder (MDD), with a focus on practical guidance regarding real world challenges. The paper includes clinical case reports,...